The Discounted Cash Flow (DCF) valuation of Dechra Pharmaceuticals PLC (DPH.L) is (258.44) GBP. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on DCF is -106.7%.
Based on the latest price of 3,866.00 GBP and our DCF valuation, Dechra Pharmaceuticals PLC (DPH.L) is a sell. selling DPH.L stocks now will result in a potential gain of 106.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 9.0% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (306.63) - (49.18) | (258.44) |
| Upside | -107.9% - -101.3% | -106.7% |